Application of the Gyrolab™ platform to ligand-binding assays: A user's perspective

Bioanalysis

Volumn 2, Issue 10, 2010, Pages 1711-1715

  Mora, Johanna R ^a   Obenauer Kutner, Linda ^a   Vimal Patel, Vimal ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; COST EFFECTIVENESS ANALYSIS; DATA ANALYSIS SOFTWARE; DRUG IMPURITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH THROUGHPUT SCREENING; HOST CELL; IMMUNOGENICITY; INTERMETHOD COMPARISON; LIGAND BINDING; MICROFLUIDICS; PHARMACOKINETICS; PROTEIN ANALYSIS; REACTION TIME; REVIEW; SENSITIVITY ANALYSIS; ARTICLE; COMPUTER PROGRAM; DRUG DEVELOPMENT; ENVIRONMENT; INSTRUMENTATION; METHODOLOGY; MICROFLUIDIC ANALYSIS; PROTEIN BINDING;

LIGAND;

DRUG DISCOVERY; ENVIRONMENT; HIGH-THROUGHPUT SCREENING ASSAYS; LIGANDS; MICROFLUIDIC ANALYTICAL TECHNIQUES; PROTEIN BINDING; SOFTWARE;

EID: 79952529219     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.122     Document Type: Review

References (11)

1. Honda N, Lindberg U, Andersson P, Hoffmann S, Takei H. Simultaneous multiple immunoassays in a compact disc-shape microfuidic device based on centrifugal force. Clin. Chem. 51(10), 1955-1961 (2005). (Pubitemid 41368195)
2. Eriksson C, Agaton C, Kange R et al. Microfuidic analysis of antibody specifcity in a compact disk format. J. Proteome Res. 5, 1568-1574 (2005). (Pubitemid 44036130)
3. Inganäs M, Dérand H, Eckerseen A et al. Integrated microfuidic compact disc device with potential use in both centralized and point of care laboratory settings. Clin. Chem. 51(10), 1985-1987 (2005). (Pubitemid 41368200)
4. Madou M, Zoval J, Jia G, Kido H, Kim K, Kim N. Lab on a CD. Annu. Rev. Biomed. Eng. 8, 601-628 (2006). (Pubitemid 44314828)
5. He H, Yuan Y, Wange W, Chiou N-R, Epstein AJ, Lee LJ. Design and testing of a microfuidic biochip for cytokine enzyme-linked immunosorbent assay Biomicrofuidics 3, 2240-2241 (2009).
6. Inganas M, Osterlund K. Reaping the benefts of assay miniaturization. Pharmaceutical Technology Europe 20(11), 1 (2008).
7. Dong H et al. Evaluation of Gyrolab Bioaffy platform to measure the concentration of protein therapeutics in human serum. Presented at: The 7th AAPS National Biotechnology Conference. Toronto, Canada, 22-25 June 2008.
8. Wang W, Bolik J, Qiu J et al. Development and validation of a bridging immunoassay using Gyros CD technology for pharmacokinetic assessment of therapeutic antibodies. Presented at: The 6th AAPS National Biotechnology Conference. San Diego, CA, USA, 24-27 June 2007
9. Prince P, Patel S, Colbert A. Evaluation of immunoassay platforms for the detection of an analyte in the prescence of high endogenous ligand concentrations. Presented at: The 8th AAPS National Biotechnology Conference. Seattle, WA, USA, 20-26 June 2009.
10. Mora JR, et al. Immunogenicity Gyrolab™ assay for the screening of anti-drug antibodies in human serum: assay development and comparison to ECL and ELISA formats. Presented at: The 7th AAPS National Biotechnology Conference. Toronto, Canada, 22-25 June 2008.
11. Gorman PN, Finco-Kent D. Comparison of an anti-drug antibody assay (ADA) using Meso-Scale Discovery's PR400 and Gyros, Inc. Gyrolab™ LIF platforms. Presented at: The 8th AAPS National Biotechnology Conference. Seattle, WA, USA, 20-26 June 2009.